CVVHF allow an effective clearance of myoglobin thanks to its low molecular weight.This case highlights the potential effectiveness of these therapies in cases of rapid renal deterioration.Conclusion: Hemoadsorption with CytoSorb represents a promising new alternative for the management of severe rhabdomyolysis-related AKI.In the case of our patient, the early use of these therapies warranted a favorable outcome free of complications.Further studies are required to establish its widespread use in this context.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Hou et al. (Wed,) studied this question.